Jump to section
Phlo is building the pharmacy of the future, allowing patients to manage their healthcare anywhere, at any time.
The COVID-19 pandemic shone a spotlight on how under pressure the UK’s NHS healthcare system was and continues to be - waiting lists and bottlenecks within facilities such as pharmacies, and the fact that patients must often be physically present at pharmacies to present documentation and collect medication. This antiquated and convoluted process could be fixed with digital solutions.
Phlo provides an online pharmacy service that allows users to manage, order, and track medication prescriptions for rapid delivery to their homes. The platform is available as an integrated mobile application, including real-time support features such as a patient-to-GP communication system.
The NHS has already provided a prescription drug delivery service to ease bottlenecks in the system, but the end-to-end nature of Phlo presents a more convenient and integrated partnership for all patients. In addition to providing these services directly to the consumers, Phlo also works with businesses and the NHS to provide the service to employees for free, to improve health and productivity in the workplace. With the 2026 announcement of a partnership with Holland & Barrett, Pho is drawing the attention of high street retailers too.

Kirsty
Company Specialist at Welcome to the Jungle
Apr 2024
$12.1m
EARLY VC
Feb 2023
$13.4m
SERIES A
This company has top investors
Adam Hunter
(CEO)Previously Board Director and Chief Commercial Officer at Phlo. Before that, worked as a Non-Exec Director for GTS Solutions CIC and was the Commercial Manager at Arbikie Distillery.